1. Home
  2. CODA vs TLSA Comparison

CODA vs TLSA Comparison

Compare CODA & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

HOLD

Current Price

$9.51

Market Cap

98.9M

Sector

Industrials

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.60

Market Cap

182.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CODA
TLSA
Founded
1994
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.9M
182.7M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
CODA
TLSA
Price
$9.51
$1.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
54.3K
373.4K
Earning Date
01-28-2026
05-06-2025
Dividend Yield
N/A
N/A
EPS Growth
15.09
N/A
EPS
0.30
N/A
Revenue
$24,347,217.00
N/A
Revenue This Year
$30.82
N/A
Revenue Next Year
$20.84
N/A
P/E Ratio
$31.70
N/A
Revenue Growth
29.34
N/A
52 Week Low
$5.76
$0.63
52 Week High
$10.54
$2.60

Technical Indicators

Market Signals
Indicator
CODA
TLSA
Relative Strength Index (RSI) 56.60 48.90
Support Level $8.80 $1.47
Resistance Level $9.60 $1.62
Average True Range (ATR) 0.44 0.16
MACD 0.01 0.01
Stochastic Oscillator 73.89 58.82

Price Performance

Historical Comparison
CODA
TLSA

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: